Collaborations

The Drugs for Neglected Diseases initiative (DNDi), founded in 2003, develops new treatments for neglected diseases and…

The Global Antimicrobial Resistance Research and Development Hub, or Global AMR R&D Hub for short, is an initiative of…

The H3D Research Centre is Africa's first integrated centre for drug discovery and development. Founded at the University of…

HYpharm GmbH and a DZIF-funded consortium are collaborating on the production and development of the phage lysine protein HY…

The "International Coalition to Eliminate HBV", or ICE-HBV, has the ambitious goal of eliminating chronic hepatitis B as a…

Together with the company IDT Biologika, the DZIF is developing a vaccine against the MERS coronavirus in a consortium of…

Multi-resistant bacteria are spreading worldwide. New antibiotics and strategies against deadly infectious diseases are…

Research foci of the "Kumasi Centre for Collaborative Research in Tropical Medicine" (KCCR) in Ghana are malaria…

McMaster University is among Canada’s most research-intensive universities and is consistently ranked in the top 20 in the…

Merck Sharp & Dohme (MSD for short) is a US pharmaceutical company. As an industry partner of the consortium INCATE…